Parent Project Muscular Dystrophy and Sarepta Therapeutics hosted a webinar on November 24, 2020 for a discussion about the SRP-9001 gene therapy development program. * This webinar recording contains edits to content requested by the company. 6 years ago Research & Clinical Trial Webinars,Webinars You may also like 1:45 Gene Therapy & Duchenne Muscular Dystrophy 8 years ago General Information gene therapy 56:15 An Update on Corticosteroids (October 2018) 8 years ago Care Webinars,Research & Clinical Trial Webinars,Webinars 44:29 Is Myostatin Still a Potential Therapeutic Target? (October 2018) 8 years ago Research & Clinical Trial Webinars,Webinars 1:00:51 Puberty and Duchenne (September 2018) 8 years ago Care Webinars,Webinars 1:09:04 HOPE-2 Duchenne Clinical Trial – Capricor (July 2018) 8 years ago Research & Clinical Trial Webinars,Webinars 1:01:35 Introducing PPMO – Sarepta Therapeutics (May 2018) 8 years ago Research & Clinical Trial Webinars,Webinars 50:18 Roche/Genentech Anti-Myostatin Adnectin RG6206 in Duchenne (May 2018) 8 years ago Research & Clinical Trial Webinars,Webinars 49:43 NS Pharma’s Exon 53 Skipping Program Update (April 2018) 8 years ago Research & Clinical Trial Webinars,Webinars «1…1920212223…30»Page 21 of 30